Finance

Lists
688278:SHA
Xiamen Amoytop Biotech Co Ltd
CNÂ¥52.05
-4.51%
(-2.46) 1D
Sep 11, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688278...
Open
CNÂ¥54.46
High
CNÂ¥54.46
Low
CNÂ¥51.85
Mkt. cap
21.25B
Avg. vol.
4.59M
Volume
3.06M
Dividend
1.19%
Quarterly dividend
CNÂ¥0.15
Ex-dividend date
May 29, 2026
P/E ratio
19.79
52-wk high
CNÂ¥89.65
52-wk low
CNÂ¥50.00
EPS
CNÂ¥2.63
No. of employees
4K
Open
CNÂ¥54.46
High
CNÂ¥54.46
Low
CNÂ¥51.85
Mkt. cap
21.25B
Avg. vol.
4.59M
Volume
3.06M
Dividend
1.19%
Quarterly dividend
CNÂ¥0.15
Ex-dividend date
May 29, 2026
P/E ratio
19.79
52-wk high
CNÂ¥89.65
52-wk low
CNÂ¥50.00
EPS
CNÂ¥2.63
No. of employees
4K
About Xiamen Amoytop Biotech Co Ltd
CEO-
Employees3.64K
FoundedAug 7, 1996
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
968.93M
1.22B
797.79M
1.04B
Cost of goods sold
77.67M
75.46M
84.14M
119.01M
Cost of revenue
77.67M
75.46M
84.14M
119.01M
Research and development expenses
105.76M
108.69M
93.64M
103.15M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
507.38M
568.29M
420.50M
433.88M
Operating expense
601.16M
702.25M
517.13M
557.60M
Total operating expenses
678.83M
777.71M
601.27M
676.61M
Operating income
290.11M
438.31M
196.53M
362.16M
Other non operating income
-174.24K
-8.36K
-397.83K
253.31K
EBT including unusual items
254.73M
444.38M
179.04M
350.45M
EBT excluding unusual items
290.62M
441.89M
198.00M
361.73M
Income tax expense
16.50M
79.26M
14.55M
38.41M
Effective tax rate
6.48%
17.84%
8.12%
10.96%
Other operating expenses
-12.89M
25.22M
3.57M
19.67M
Net income
238.23M
365.11M
164.49M
312.03M
Net profit margin
24.59%
30.03%
20.62%
30.04%
Earnings per share
0.60
0.96
-
0.80
Interest and investment income
1.24M
4.63M
2.56M
1.93M
Interest expense
-384.44K
-660.14K
-686.79K
-1.76M
Net interest expenses
853.64K
3.97M
1.88M
173.29K
Depreciation and amortization charges
-
-
-
-
EBITDA
306.99M
466.76M
224.97M
398.98M
Gain or loss from assets sale
21.30K
987.25K
-
-1.66M
AI content may include mistakes. Learn more
Google apps